Having been mostly investigated in the context of neoplasms, targeting the Tiam1/Rac1 complex either genetically or using pharmacological inhibitors has shown the ability to deter proliferative ability of several tumours30, 48 in addition to primary cells49, 50. This evidence concerns the gene RAC1 and neoplasm.